Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Intas Pharma

Eli Lilly HQ

German court overturns patent on Lilly blockbuster Alimta

Verdict means Actavis can launch generic after December

- PMLiVE

Actavis gets FDA nod for new antibiotic

Avycaz is the fifth antibiotic to gain US approval in recent months

France flag

French pharma growth restricted by generics

New analysis finds country’s market value will grow only modestly in the coming years

- PMLiVE

AZ gets injunction to protect Pulmicort Respules

Actavis blocked from selling generic five days after AZ’s asthma launch

- PMLiVE

UK CROs to offer drug discovery services to Nordic businesses

Will head to Copenhagen in March for market visit

- PMLiVE

AZ loses Pulmicort Respules protection in US

Court also denied AZ’s request for a permanent injunction

Sanofi reception

Generic competition for Sanofi’s Renvela hits UK market

Teva and others launch cheaper versions of the chronic kidney disease drug

Sanofi reception

Generic competition for Sanofi’s Renvela hits UK market

Teva and others launch cheaper versions of the chronic kidney disease drug

- PMLiVE

Deal Watch table for January 2015

Table listing all the major pharma mergers, acquisitions and collaborations in the past month

- PMLiVE

Pharma deals during January 2015

Deal Watch: Major pharma collaborations, acquisitions and agreements in the past month

- PMLiVE

AZ adds to respiratory portfolio with Actavis drugs

Follows deal to acquire Almirall’s franchise in asthma and COPD

Searching for junk

The pharma industry might be focusing on the wrong acquisitions

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links